242 related articles for article (PubMed ID: 27906855)
21. Orbital exenteration for advanced periorbital skin cancers: 20 years experience.
Nassab RS; Thomas SS; Murray D
J Plast Reconstr Aesthet Surg; 2007; 60(10):1103-9. PubMed ID: 17434350
[TBL] [Abstract][Full Text] [Related]
22. Recurrence rates of periocular basal cell carcinoma following intra-operative en-face frozen section margin controlled excision.
McCabe GA; Mulcahy LT; Mulligan N; Fulcher T
Ir J Med Sci; 2024 Jun; 193(3):1209-1213. PubMed ID: 38289579
[TBL] [Abstract][Full Text] [Related]
23. 5 years review of periocular basal cell carcinoma and proposed follow-up protocol.
Ho SF; Brown L; Bamford M; Sampath R; Burns J
Eye (Lond); 2013 Jan; 27(1):78-83. PubMed ID: 23154501
[TBL] [Abstract][Full Text] [Related]
24. Supraestructure maxillectomy and orbital exenteration for treatment of basal cell carcinoma of inferior eyelid: case report and review.
Villalon-Lopez JS; Valle-Mejia CA; Patino-Lara A; Moreno-Perez BA; Munoz-Lopez JA; Alcantar-Andrade A
J Cancer Res Ther; 2006; 2(3):140-3. PubMed ID: 17998694
[TBL] [Abstract][Full Text] [Related]
25. Orbital exenteration: a 13 year Manchester experience.
Rahman I; Cook AE; Leatherbarrow B
Br J Ophthalmol; 2005 Oct; 89(10):1335-40. PubMed ID: 16170127
[TBL] [Abstract][Full Text] [Related]
26. Orbital exenteration: a 10-year experience of a general oncology hospital.
Soysal HG
Orbit; 2010 Jun; 29(3):135-9. PubMed ID: 20497078
[TBL] [Abstract][Full Text] [Related]
27. Recurrence Following Globe Sparing Excision for Basal Cell Carcinoma with Anterior Orbital Invasion.
Tong JY; Martin PA; Tumuluri K; Selva D
Ophthalmic Plast Reconstr Surg; 2023 Jul-Aug 01; 39(4):374-380. PubMed ID: 36852833
[TBL] [Abstract][Full Text] [Related]
28. Tension Pneumocephalus Following Orbital Exenteration.
Shieh WS; Farrell C; Curry J; Murchison AP; Bilyk JR
Ophthalmic Plast Reconstr Surg; 2016; 32(1):e3-5. PubMed ID: 25689788
[TBL] [Abstract][Full Text] [Related]
29. Management of periocular basal and squamous cell carcinoma: a series of 485 cases.
Nemet AY; Deckel Y; Martin PA; Kourt G; Chilov M; Sharma V; Benger R
Am J Ophthalmol; 2006 Aug; 142(2):293-7. PubMed ID: 16876511
[TBL] [Abstract][Full Text] [Related]
30. [Clinical and histologic features of 141 primary basal cell carcinomas of the periocular region and their rate of recurrence after surgical excision].
Spraul CW; Ahr WM; Lang GK
Klin Monbl Augenheilkd; 2000 Oct; 217(4):207-14. PubMed ID: 11098454
[TBL] [Abstract][Full Text] [Related]
31. Orbital exenteration for secondary orbital tumors: a series of seven cases.
Lin HF; Lui CC; Hsu HC; Lin SA
Chang Gung Med J; 2002 Sep; 25(9):599-605. PubMed ID: 12479621
[TBL] [Abstract][Full Text] [Related]
32. Orbital invasion by periocular infiltrating Basal cell carcinoma.
Zeitouni NC; Raghu PR; Mansour TN
Dermatol Surg; 2012 Dec; 38(12):2025-7. PubMed ID: 22861659
[No Abstract] [Full Text] [Related]
33. [Exenteration of the Orbit for Basal Cell Carcinoma].
Furdová A; Horkovičová K; Krčová I; Krásnik V
Cesk Slov Oftalmol; 2015 Aug; 71(4):209-16. PubMed ID: 26395856
[TBL] [Abstract][Full Text] [Related]
34. How can we decide on orbital exenteration for second eye in a patient with basal cell carcinoma?
Copcu E; Sivrioglu N; Baytekin C; Er S; Koc B
Plast Reconstr Surg; 2006 Jun; 117(7):2512-4. PubMed ID: 16772980
[No Abstract] [Full Text] [Related]
35. Vismodegib as Eye-Sparing Neoadjuvant Treatment for Locally Advanced Periocular Basal Cell Carcinoma.
Angnardo L; Humeda Y; Alexandraki I; Wolfe CM; Cognetta AB
J Drugs Dermatol; 2021 May; 20(5):552-554. PubMed ID: 33938701
[TBL] [Abstract][Full Text] [Related]
36. Vismodegib for periocular and orbital basal cell carcinoma.
Gill HS; Moscato EE; Chang AL; Soon S; Silkiss RZ
JAMA Ophthalmol; 2013 Dec; 131(12):1591-4. PubMed ID: 24136169
[TBL] [Abstract][Full Text] [Related]
37. [Recurrence risk of periocular basal cell carcinoma after histologically controlled excision].
Dethmers A; Löw U; Langenbucher A; Flockerzi F; Bohle RM; Seitz B
Ophthalmologie; 2023 Mar; 120(3):285-293. PubMed ID: 36112203
[TBL] [Abstract][Full Text] [Related]
38. Orbital Exenteration to Manage Infiltrative Sinonasal, Orbital Adnexal, and Cutaneous Malignancies Provides Acceptable Survival Outcomes: An Institutional Review, Literature Review, and Meta-Analysis.
Hoffman GR; Jefferson ND; Reid CB; Eisenberg RL
J Oral Maxillofac Surg; 2016 Mar; 74(3):631-43. PubMed ID: 26475973
[TBL] [Abstract][Full Text] [Related]
39. Multicentred international review of orbital exenteration and reconstruction in oculoplastic and orbit practice.
Zhang Z; Ho S; Yin V; Varas G; Rajak S; Dolman PJ; McNab A; Heathcote JG; Valenzuela A
Br J Ophthalmol; 2018 May; 102(5):654-658. PubMed ID: 28844052
[TBL] [Abstract][Full Text] [Related]
40. Mortality following exenteration for malignant tumours of the orbit.
Rahman I; Maino A; Cook AE; Leatherbarrow B
Br J Ophthalmol; 2005 Nov; 89(11):1445-8. PubMed ID: 16234450
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
